CVS Health Co. (NYSE:CVS) Shares Sold by Cutler Investment Counsel LLC

Cutler Investment Counsel LLC decreased its holdings in shares of CVS Health Co. (NYSE:CVS) by 1.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 150,937 shares of the pharmacy operator’s stock after selling 2,894 shares during the quarter. CVS Health makes up approximately 1.7% of Cutler Investment Counsel LLC’s holdings, making the stock its 20th biggest holding. Cutler Investment Counsel LLC’s holdings in CVS Health were worth $11,918,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. Moneta Group Investment Advisors LLC lifted its stake in CVS Health by 103,371.0% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 15,547,559 shares of the pharmacy operator’s stock valued at $1,448,877,000 after buying an additional 15,532,533 shares during the last quarter. Norges Bank bought a new position in CVS Health in the 4th quarter worth about $1,425,416,000. FMR LLC increased its stake in shares of CVS Health by 29.1% in the third quarter. FMR LLC now owns 27,487,238 shares of the pharmacy operator’s stock valued at $1,919,159,000 after purchasing an additional 6,194,441 shares during the period. Morgan Stanley raised its holdings in shares of CVS Health by 10.9% during the fourth quarter. Morgan Stanley now owns 33,576,388 shares of the pharmacy operator’s stock valued at $3,128,984,000 after buying an additional 3,311,928 shares during the last quarter. Finally, Barclays PLC boosted its position in shares of CVS Health by 97.8% during the second quarter. Barclays PLC now owns 5,483,154 shares of the pharmacy operator’s stock worth $379,052,000 after buying an additional 2,711,102 shares during the period. 80.66% of the stock is owned by institutional investors.

Insider Activity

In related news, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.24% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Cantor Fitzgerald reissued an “overweight” rating and issued a $87.00 price target on shares of CVS Health in a research note on Wednesday, April 10th. HSBC started coverage on shares of CVS Health in a research note on Friday, December 22nd. They set a “buy” rating and a $94.00 target price on the stock. Piper Sandler upped their price target on shares of CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, March 15th. Wells Fargo & Company lowered their price objective on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating on the stock in a research note on Monday, April 8th. Finally, SVB Leerink initiated coverage on CVS Health in a research report on Monday, February 26th. They issued an “outperform” rating and a $88.00 target price for the company. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $89.44.

CVS Health Trading Up 1.5 %

Shares of NYSE CVS traded up $1.02 during mid-day trading on Friday, hitting $69.75. 4,547,743 shares of the company traded hands, compared to its average volume of 10,810,119. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. CVS Health Co. has a 1 year low of $64.41 and a 1 year high of $83.25. The stock has a market capitalization of $87.92 billion, a price-to-earnings ratio of 10.75, a PEG ratio of 0.91 and a beta of 0.52. The business has a 50 day moving average of $75.42 and a two-hundred day moving average of $73.70.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The company had revenue of $93.81 billion during the quarter, compared to analysts’ expectations of $90.58 billion. During the same period last year, the company posted $1.99 earnings per share. The business’s revenue for the quarter was up 11.9% on a year-over-year basis. On average, sell-side analysts anticipate that CVS Health Co. will post 8.32 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.81%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health’s dividend payout ratio (DPR) is currently 41.18%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.